CD19 Receptor Interactions [MoA] - N0000193544
Pharmacologic Class Information
| Pharmacologic Code | N0000193544 |
| Pharmacologic Name | CD19 Receptor Interactions |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with CD19 Receptor Interactions
The table contains 3 products whose active ingredient are classified under the same pharmacologic class CD19 Receptor Interactions [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0846 | Kymriah | Non-Proprietary Name: Tisagenlecleucel | Injection, Suspension | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 0078-0958 | Kymriah | Non-Proprietary Name: Tisagenlecleucel | Injection, Suspension | Intravenous | Novartis Pharmaceuticals Corporation | ACTIVE | |
| 71287-119 | Yescarta | Non-Proprietary Name: Axicabtagene Ciloleucel | Suspension | Intravenous | Kite Pharma, Inc. | ACTIVE |